Bon Natural Life Launches Breakthrough AI-Powered Drug Discovery Platform
Bon Natural Life Limited has officially launched its artificial intelligence (AI)-driven drug research and development (R&D) division.
This move represents a major step in the company’s shift towards pharmaceutical innovation.
The company plans to use AI to identify promising lead compounds from its large collection of natural bioactive ingredients, many of which are rooted in Traditional Chinese Medicine (TCM).
A lead compound is a molecule with biological activity that serves as a starting point for developing new drugs.
With close to 20 years of experience in developing natural products, Bon has built a strong library of compounds known for their therapeutic potential.
In the past, progress in drug discovery was limited by traditional screening methods. The new AI-based approach is expected to greatly improve the speed, accuracy, and success rate of identifying viable drug candidates.
This development marks a strategic shift for Bon Natural Life as it deepens its focus on innovation in the pharmaceutical sector by combining its natural compound expertise with modern AI technology.
